⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 20, 2023Journal of Cystic FibrosisOpen Access

Decline in HbA1c during the first year of elexacaftor/tezacaftor/ivacaftor treatment in the Danish cystic fibrosis cohort

Bibi Uhre Nielsen Mette Frahm Olsen Inger Hee Mabuza Mathiesen Tacjana Pressler Christian Ritz Terese L. Katzenstein Hanne Vebert Olesen Marianne Skov Søren Jensen‐Fangel Thomas Almdal Daniel Faurholt‐Jepsen

View Full Paper

Ask AI

Bookmark

Share

Abstract

In the Danish CF cohort, HbA1c declined over 12 months of ETI treatment, however, among a subset with CFRD, we observed no change in insulin usage and CGM glucose levels.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nielsen et al. (2023) studied this question.

synapsesocial.com/papers/69edb3977beaa90d72fab917 https://doi.org/10.1016/j.jcf.2023.11.005

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Cystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and MortalityOriginal Research · 2009 · 650 citations
2Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infectionsRetrospective Study · 1994 · 210 citations
3Clinical Care Guidelines for Cystic Fibrosis–Related DiabetesOriginal Research · 2010 · 726 citations
4Hypoglycemia in cystic fibrosis: Prevalence, impact and treatmentReview · 2019 · 28 citations
5Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure2018 · 71 citations

More related papers

Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries2019
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range2019
Translating the A1C Assay Into Estimated Average Glucose Values2008

More from Journal of Cystic Fibrosis

Microbial content versus microbial interaction: the impact of medications on CF airway microbial ecosystemsTue,
The cystic fibrosis gut microbial dysbiosis index (CF-GMDI): a quantitative measure of gut microbial imbalance in children with cystic fibrosisTue,